Immunological predictors of HIV-related survival

Jacques Baillargeon, James Grady, Michael J. Borucki

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

While the prognostic role of CD4 lymphocyte count is well established, little is known about how other immunological factors are associated with HIV-related survivorship. CD8 lymphocyte count is reported to inhibit growth of HIV in vitro and to deter the development of cytomeglovirus infections. Scarce information exists, however, on its association with HIV-related survivorship. The objective of the present study therefore was to assess whether survival estimation could be improved by including CD8 lymphocyte count as a prognostic factor. The study sample consisted of 904 adult HIV-infected patients who were treated between 1992 and 1997 at a large southwestern academic medical centre in the US. Survival analysis using proportional hazards modelling showed that baseline CD4 lymphocyte was highly and positively predictive of HIV-related survival. By contrast, baseline CD8 count was not predictive of survival in the study cohort. While the interaction between CD4 and CD8 was not statistically significant in the present study sample, decomposition of this effect indicates that these factors may operate synergistically to predict survival. In conclusion, these findings suggest that clinicians may improve their prognostic accuracy by relying on both CD4 and CD8 lymphocyte counts rather than relying exclusively on CD4 counts.

Original languageEnglish (US)
Pages (from-to)467-470
Number of pages4
JournalInternational Journal of STD and AIDS
Volume10
Issue number7
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

HIV
CD4 Lymphocyte Count
Survival
Lymphocyte Count
Survival Rate
Immunologic Factors
Survival Analysis
Cohort Studies
Lymphocytes
Growth
Infection

Keywords

  • CD8 lymphocyte count
  • Epidemiology
  • Survival
  • Survival analysis

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Immunology

Cite this

Immunological predictors of HIV-related survival. / Baillargeon, Jacques; Grady, James; Borucki, Michael J.

In: International Journal of STD and AIDS, Vol. 10, No. 7, 1999, p. 467-470.

Research output: Contribution to journalArticle

Baillargeon, Jacques ; Grady, James ; Borucki, Michael J. / Immunological predictors of HIV-related survival. In: International Journal of STD and AIDS. 1999 ; Vol. 10, No. 7. pp. 467-470.
@article{e8930dc0016f4deb86e30d36aa6c0c5a,
title = "Immunological predictors of HIV-related survival",
abstract = "While the prognostic role of CD4 lymphocyte count is well established, little is known about how other immunological factors are associated with HIV-related survivorship. CD8 lymphocyte count is reported to inhibit growth of HIV in vitro and to deter the development of cytomeglovirus infections. Scarce information exists, however, on its association with HIV-related survivorship. The objective of the present study therefore was to assess whether survival estimation could be improved by including CD8 lymphocyte count as a prognostic factor. The study sample consisted of 904 adult HIV-infected patients who were treated between 1992 and 1997 at a large southwestern academic medical centre in the US. Survival analysis using proportional hazards modelling showed that baseline CD4 lymphocyte was highly and positively predictive of HIV-related survival. By contrast, baseline CD8 count was not predictive of survival in the study cohort. While the interaction between CD4 and CD8 was not statistically significant in the present study sample, decomposition of this effect indicates that these factors may operate synergistically to predict survival. In conclusion, these findings suggest that clinicians may improve their prognostic accuracy by relying on both CD4 and CD8 lymphocyte counts rather than relying exclusively on CD4 counts.",
keywords = "CD8 lymphocyte count, Epidemiology, Survival, Survival analysis",
author = "Jacques Baillargeon and James Grady and Borucki, {Michael J.}",
year = "1999",
doi = "10.1258/0956462991914483",
language = "English (US)",
volume = "10",
pages = "467--470",
journal = "International Journal of STD and AIDS",
issn = "0956-4624",
publisher = "SAGE Publications Ltd",
number = "7",

}

TY - JOUR

T1 - Immunological predictors of HIV-related survival

AU - Baillargeon, Jacques

AU - Grady, James

AU - Borucki, Michael J.

PY - 1999

Y1 - 1999

N2 - While the prognostic role of CD4 lymphocyte count is well established, little is known about how other immunological factors are associated with HIV-related survivorship. CD8 lymphocyte count is reported to inhibit growth of HIV in vitro and to deter the development of cytomeglovirus infections. Scarce information exists, however, on its association with HIV-related survivorship. The objective of the present study therefore was to assess whether survival estimation could be improved by including CD8 lymphocyte count as a prognostic factor. The study sample consisted of 904 adult HIV-infected patients who were treated between 1992 and 1997 at a large southwestern academic medical centre in the US. Survival analysis using proportional hazards modelling showed that baseline CD4 lymphocyte was highly and positively predictive of HIV-related survival. By contrast, baseline CD8 count was not predictive of survival in the study cohort. While the interaction between CD4 and CD8 was not statistically significant in the present study sample, decomposition of this effect indicates that these factors may operate synergistically to predict survival. In conclusion, these findings suggest that clinicians may improve their prognostic accuracy by relying on both CD4 and CD8 lymphocyte counts rather than relying exclusively on CD4 counts.

AB - While the prognostic role of CD4 lymphocyte count is well established, little is known about how other immunological factors are associated with HIV-related survivorship. CD8 lymphocyte count is reported to inhibit growth of HIV in vitro and to deter the development of cytomeglovirus infections. Scarce information exists, however, on its association with HIV-related survivorship. The objective of the present study therefore was to assess whether survival estimation could be improved by including CD8 lymphocyte count as a prognostic factor. The study sample consisted of 904 adult HIV-infected patients who were treated between 1992 and 1997 at a large southwestern academic medical centre in the US. Survival analysis using proportional hazards modelling showed that baseline CD4 lymphocyte was highly and positively predictive of HIV-related survival. By contrast, baseline CD8 count was not predictive of survival in the study cohort. While the interaction between CD4 and CD8 was not statistically significant in the present study sample, decomposition of this effect indicates that these factors may operate synergistically to predict survival. In conclusion, these findings suggest that clinicians may improve their prognostic accuracy by relying on both CD4 and CD8 lymphocyte counts rather than relying exclusively on CD4 counts.

KW - CD8 lymphocyte count

KW - Epidemiology

KW - Survival

KW - Survival analysis

UR - http://www.scopus.com/inward/record.url?scp=0032998070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032998070&partnerID=8YFLogxK

U2 - 10.1258/0956462991914483

DO - 10.1258/0956462991914483

M3 - Article

VL - 10

SP - 467

EP - 470

JO - International Journal of STD and AIDS

JF - International Journal of STD and AIDS

SN - 0956-4624

IS - 7

ER -